共 14 条
[1]
Nishikaw a M,Tsurum iY,MuraiH,etal.WF-2421+ , a new aldose reductase inhibitor producedfrom a fungus, Hum icola grisea. Journal of Antibiotics . 1991
[2]
Horie S,NagaiH,YuukiT,et al.Effect of SG-210, a novel aldose reductase inhibitor, on im -paired polyol pathw ay in rats received diabeticm anipulations. Journal of Diabetes and Its Complications . 1998
[3]
Hotta N,Sakam oto N,Shigeta Y,etal.Clinicalinvestigation of epalrestat, an aldose reductaseinhibitor, on diabetic neuropathy in Japan: m ulti-center study.Diabetic neuropathy study group inJapan. Journal of Diabetes and Its Complications . 1996
[4]
van Griensven JM,Jusko W J,Lem kes HH,etal.Tolrestatpharm acokinetic and pharm acodyna-m ic effects on red blood cellsorbitollevels in nor-m alvolunteers and in patients w ith insulin-depen-dent diabetes. Clinical Pharmacology and Therapeutics . 1995
[5]
Petrash JM,Tarle I,W ilson DK,et al.Aldosereductase catalysis and crystallography.Insightsfrom recent advances in enzym e structure andfunction. Diabetes . 1994
[6]
Luca C,Giulio R,Paola V,etal.Diabetes com -plication and their potential prevention and otherapproaches. Medicinal Research Reviews . 1999
[7]
Ashizaw a N,Yoshida M,Sugiyam a Y,etal.Ef-fects of a novelpotent aldose reductase inhibitor,GP-1447, on aldose reductase activity in vitro andon diabetic neuropathy and cataract form ation inrats. Jpn J Pharm acol . 1997
[8]
Murakam iN,Ohta M,Kato K,et al.Effects of1-( 3-brom obenzofuran-2-yl-sulfonyl) hydantoinon hum an aldose reductase exam ined by a newapplication of HPLC system for m easuring tissuepolyol. Arzneimittel Forschung Drug Research . 1997
[9]
Nicolucci A,Carinci F,Graepel JG,et al.Theefficacy of tolrestat in the treatm ent of diabeticperipheral neuropathy.A m eta-analysis of indi-vidualpatientdata. Diabetes Care . 1996
[10]
W ilson DK,Bohren KM,Gabbay KH,et al.Anunlikely sugar substrate site in the 1.65A struc-ture of the hum an aldose reductase holoenzym eim plicated in diabetic com plications. Science . 1992